← Open Payments lookup

MADALYN QUALIZZA: Open Payments

NPI 1962163691 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$631 in 26 payments from 19 companies in 2025. Trend: 2023 $325 · 2024 $403 · 2025 $631

Food & beverage: $631
CompanyPaymentsAmount
ABBVIE INC.3$75
AstraZeneca Pharmaceuticals LP3$58
Incyte Corporation2$50
Novartis Pharmaceuticals Corporation2$45
Merck Sharp & Dohme LLC2$42
Takeda Pharmaceuticals U.S.A., Inc.1$36
Boehringer Ingelheim Pharmaceuticals, Inc.1$35
BeOne Medicines USA, Inc.1$34
Syndax Pharmaceuticals, Inc.1$34
JAZZ PHARMACEUTICALS INC.1$29

Products named: SCEMBLIX, KEYTRUDA, ICLUSIG, TEVIMBRA, EPKINLY, ELAHERE, ZEPZELCA, JAKAFI.

Industry payments across IN — which companies pay providers there.